VA Central California Health System, 2615 E Clinton Ave, Fresno, CA 93703, USA; University of California San Francisco, UCSF Fresno Medical Education Program, 155 N. Fresno Street, Fresno, CA 93701-2302, USAUnited States
Also available as PDF (figures and tables appear in the PDF).
Migration is the most common complication of placing an esophageal fully covered self-expanding metal stent (FCSEMS). Prior Studies have demonstrated high migration rates of FCSEMS leading to additional invasive procedures.1 We report a case of esophageal FCSEMS placement with endoscopic suturing which prevented migration of the stent and a successful post procedure course.
igration is the most common complication of placing an esophageal fully covered self-expanding metal stent (FC- M SEMS). Prior Studies have demonstrated high migration rates of FCSEMS leading to additional invasive procedures.1 We report a case of esophageal FCSEMS placement with endoscopic suturing which prevented migration of the stent and a successful post procedure course.
A 68-year-old male presented with complaints of heartburn and progressive dysphagia for solid food. His past medical history was remarkable for coronary artery disease with coronary stent placement in 2008 and 2009 and gastroesophageal reflux disease (GERD). His family history was significant for esophageal cancer in brother diagnosed at the age of 53 years. Physical examination was significant for epigastric tenderness but the rest of the examination was otherwise unremarkable. Labs were significant for iron deficiency anemia: hemoglobulin 10.3 gm/dL, hematocrit 31.1%, MCV 87%, iron 24 mcg/dL, transferrin saturation 7 mcg/dL. A computed tomography (CT) scan of abdomen and pelvis with contrast performed to evaluate iron deficiency anemia showed marked circumferential thickening of the visualized portion of the distal esophagus extending to the gastroesophageal GE junction, which was suspicious for esophageal cancer. There was an enlarged lymph node of the gastro-hepatic ligament suspicious for metastasis. Upper endoscopy was performed which showed a large, fungating and ulcerating mass with no bleeding in the mid and distal esophagus. The mass was partially obstructing and circumferential. It extended from mid esophagus to GE junction (Figure 1). Biopsies were taken with cold forceps for histology, which showed
cc Copyright 2018 by Saligram S. This is an open-access article distributed under Creative Commons Attribution 4.0 International License (CC BY 4.0), which allows poorly differentiated adenocarcinoma with signet-ring cell type with background of Barrett’s esophagus with high-grade dysplasia and positive Her2/neu overexpression by immunohistochemistry stain.
Endoscopic ultrasound showed hypoechoic mass in the middle third of the esophagus and in the lower third of the esophagus. The mass was encountered at 30 cm from the incisors and extended to 40 cm. The lesion was circumferential. The endosonographic borders were poorly defined. There was sonographic evidence suggesting invasion into the adventitia. (Layer 5) Two malignant-appearing lymph nodes were visualized in the lower para-esophageal mediastinum (level 8L). The largest measured was 8 mm by 7 mm, in maximal cross-sectional diameter. The nodes were round, hypoechoic and had well-defined margins. A diagnosis of T3N1MX (stage IIIa) esophageal adenocarcinoma was made (Figure 2).
He then underwent upper endoscopy for stent placement for palliation of symptoms of dysphagia from his esophageal adenocarcinoma. The large, fungating and ulcerating esophageal mass was stented with a 23 mm × 150 mm EndoMaxx FCSEMS (Figure 3). The proximal end of the stent was at 28 cm. The stent was then secured with two sutures by an overstitch to prevent migration (Figure 4). There was no immediate complication like post procedure pain, bleeding or perforation from securing the stent with the overstitch.
He was treated with chemotherapy and radiation therapy by oncology for 5 weeks with plans for surgical resection following chemo-radiation. He underwent repeat esophagogastroduodenoscopy (EGD) 8 weeks later when the overstitch was removed Gastro Open J. 2017; 3(1): 1-3. doi: 10.17140/GOJ-3-127
Figure 1. Esophageal Tumor
Esophageal stents are frequently placed to palliate symptoms in patients with malignant esophageal strictures.2,3 Esophageal stents can be used to improve symptomatic esophageal lesions from benign esophageal strictures, perforations, fistulae, and leaks. However, esophageal stents have been associated with various complications including stent migration, which can happen in 40%-60% of patients who undergo this procedure.1 Other complications are severe chest pain, bleeding, fistula formation, ulceration, tissue em- 8,9 bedding, and reflux.
Uncovered and partially covered self-expanding metal stents are secure and resist migration due to tissue in-growth. They
Figure 2. EUS Examination Showing Tumor Infiltration into Adventitia
However, they are permanent stents and will come in the way of future surgery. Also, they are at risk of future stent occlusion due to tumor in-growth and can cause fistula. Therefore, the patients are subjected to additional invasive procedures due to complications from permanent esophageal self-expanding metal stent. 2,3 The FCSEMS are temporary stents and rely on radial fric- 4-7 tion against the esophageal mucosa to hold the stent in place. The nitinol coating is designed to resist tissue ingrowth and this coating allows for the metal stent to be removed after the several weeks 1 3,4 of stent placement.3,4 Stent migration represents the most common adverse event of the FCSEMS with migration rates between 1,9 30% and 60%. Techniques to prevent stent migration using endoscopic clips have been described but are ineffective and associ- 10-13 ated with a high rate of complications. Esophageal stent fixation by endoscopic suturing with an overstitch is a novel technique that prevents esophageal stent migration in an ex vivo setting.14 Few Gastro Open J. 2017; 3(1): 1-3. doi: 10.17140/GOJ-3-127
studies have reported successful use of Overstitch for fixation of FCSEMS to prevent spontaneous migration of esophageal stents. The reported migration rate after securing the stent with overstitch 15-18 is 8-16%. The migration despite Overstitch is due to esophageal peristalsis and mostly seen in non-malignant indications for the stent where there is no stricture to keep the stent in place.
OverStitch (Apollo Endosurgery) is the most widely used endoscopic suturing device. The device assembly and use are straightforward and closely resemble surgical suturing. Our patient never experienced peri-procedural complications during the procedure of stent fixation by the overstitch. There was no evidence of procedure-related pain, bleed or perforation. Also, post procedure, there was no evidence of dysphagia or migration during his treatment with chemo-radiation when the risk for migration is high due to tumor shrinkage and stricture resolution. The overstitch is easy to remove along with the stent as was demonstrated in our case. Endoscopic suturing can effectively prevent spontaneous migration of esophageal stents. Although, there is a learning curve for the endoscopists to master the technique of endoscopic suturing with the Overstitch device, this should be the standard of care for placement of esophageal stents.
The authors declare that they have no conflicts of interest.